Platelets are very commonly prescribed blood components and in many settings their use is increasing. They may be used either prophylactically (to attempt to prevent bleeding) or therapeutically (to treat bleeding when it occurs). This review provides a summary of the major clinical settings in which platelet transfusions are currently used. Most platelet transfusions are provided prophylactically to thrombocytopenic haematology/oncology patients, although bleeding risks and rates appear to vary substantially between individual patients. Other contexts include major haemorrhage, surgery and invasive procedures, and patients in critical care and neonatal intensive care. Since platelet transfusions carry risks and costs, and evidence of benef...
Background: Platelet transfusions are administered to prevent or treat bleeding in patients with qua...
People with haematological malignancies are the largest patient group who use platelet components, a...
Patients with severe thrombocytopenia are presumed to be at increased risk for bleeding, and consequ...
Relevance of platelet transfusion is related to an increasing number of indications due to condition...
The threshold for transfusing platelets in the pediatric hematology/oncology population is not stand...
Patients with severe thrombocytopenia are presumed to be at increased risk for bleeding, and consequ...
BACKGROUND: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
BACKGROUND AND OBJECTIVES: A large proportion of all platelet components are given to haematology pa...
Background Platelet transfusions are used in modern clinical practice to prevent and treat bleeding ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
This thesis focused on the balance of platelet transfusion benefits and risks in patients with a low...
The following are indications for platelet transfusion in leukemia, aplastic anemia, idiopathic thro...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
Purpose of review: This review highlights the recent research on the use of prophylactic platelet tr...
Background: Platelet transfusions are commonly used to treat critically ill patients with thrombocyt...
Background: Platelet transfusions are administered to prevent or treat bleeding in patients with qua...
People with haematological malignancies are the largest patient group who use platelet components, a...
Patients with severe thrombocytopenia are presumed to be at increased risk for bleeding, and consequ...
Relevance of platelet transfusion is related to an increasing number of indications due to condition...
The threshold for transfusing platelets in the pediatric hematology/oncology population is not stand...
Patients with severe thrombocytopenia are presumed to be at increased risk for bleeding, and consequ...
BACKGROUND: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
BACKGROUND AND OBJECTIVES: A large proportion of all platelet components are given to haematology pa...
Background Platelet transfusions are used in modern clinical practice to prevent and treat bleeding ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
This thesis focused on the balance of platelet transfusion benefits and risks in patients with a low...
The following are indications for platelet transfusion in leukemia, aplastic anemia, idiopathic thro...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
Purpose of review: This review highlights the recent research on the use of prophylactic platelet tr...
Background: Platelet transfusions are commonly used to treat critically ill patients with thrombocyt...
Background: Platelet transfusions are administered to prevent or treat bleeding in patients with qua...
People with haematological malignancies are the largest patient group who use platelet components, a...
Patients with severe thrombocytopenia are presumed to be at increased risk for bleeding, and consequ...